Description The purpose of this best practice advice article is to describe the role of Barrett's
endoscopic therapy (BET) in patients with Barrett's esophagus (BE) with dysplasia and/or …

OBJECTIVES: Endoscopic ablation of Barrett's esophagus can bury metaplastic glands
under a layer of neosquamous epithelium. To explore the frequency and importance of …

These guidelines provide a practical and evidence-based resource for the management of
patients with Barrett's oesophagus and related early neoplasia. The Appraisal of Guidelines …

Background & Aims Barrett's esophagus–associated high-grade dysplasia is commonly
treated by endoscopy. However, most guidelines offer no recommendations for endoscopic …

Objective Radiofrequency ablation (RFA)±endoscopic resection (ER) is the preferred
treatment for early neoplasia in Barrett's oesophagus (BE). We aimed to report short-term …

Objective Reported malignant progression rates for low-grade dysplasia (LGD) in Barrett's
oesophagus (BO) vary widely. Expert histological review of LGD is advised, but limited data …

Objective After focal endoscopic resection (ER) of high-grade dysplasia (HGD) or early
cancer (EC) in Barrett's oesophagus (BO), eradication of all remaining BO reduces the …

BACKGROUND & AIMS: Radiofrequency ablation (RFA) is an established treatment for
dysplastic Barrett's esophagus (BE). Although short-term end points of ablation have been …

Background & Aims For patients with Barrett's esophagus, the diagnosis of low-grade
dysplasia (LGD) is subjective, and reported outcomes vary. We analyzed data from a …

Background and Aims Previous estimates of incidence of intestinal metaplasia (IM)
recurrence after achieving complete remission of IM (CRIM) through endoscopic therapy of …